AIM To investigate the real-world efficacy and safety of sofosbuvir/ribavirin(SOF/RBV)therapy for Japanese patients with genotype 2 hepatitis C virus(GT2-HCV).M
This review intends to uncover how information from large-scale genetic profiling(whole genome sequencing,and whole exome sequencing)of nonalcoholic fatty liver